Sinovac widens foreign bribery probe after Chinese court judgments

Vaccine developer Sinovac Biotech has expanded an internal foreign bribery investigation after Chinese courts issued judgments against government officials that also referred to salespeople connected to the company.

Get unlimited access to all Global Investigations Review content